Iobenzamic acid
Chemical compound
- V08AC05 (WHO)
- 3-[1-(3-amino-2,4,6-triiodophenyl)-N-phenylformamido]propanoic acid
- 3115-05-7
- 18377
- DB13428
- 17355
- F72UWG2SWK
- D01313
- DTXSID9057711
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- Ic1c(c(I)c(N)c(I)c1)C(=O)N(c2ccccc2)CCC(=O)O
InChI
- InChI=1S/C16H13I3N2O3/c17-10-8-11(18)15(20)14(19)13(10)16(24)21(7-6-12(22)23)9-4-2-1-3-5-9/h1-5,8H,6-7,20H2,(H,22,23)
- Key:FJYJNLIEGUTPIJ-UHFFFAOYSA-N
Iobenzamic acid is a pharmaceutical drug used as an X-ray contrast agent.[1]
It is a water-soluble, hepatotropic contrast medium, meaning it is taken up by the liver and gallbladder. This makes it useful for imaging these organs.[2]
See also
- Iodinated contrast
References
- v
- t
- e
Contrast media (V08)
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e